Page last updated: 2024-08-23

edatrexate and Carcinoma, Hepatocellular

edatrexate has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bready, B; Fueger, RH; Giannone, L; Levin, B; Lin, YG; Maldonado, A; Moore, DF; Pazdur, R; Winn, RJ	1

Trials

1 trial(s) available for edatrexate and Carcinoma, Hepatocellular

Article	Year
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7 Topics: Adult; Aged; Agranulocytosis; alpha-Fetoproteins; Aminopterin; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Folic Acid Antagonists; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Thrombocytopenia	1994

Article

Year

Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

Topics: Adult; Aged; Agranulocytosis; alpha-Fetoproteins; Aminopterin; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Folic Acid Antagonists; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Thrombocytopenia

1994